Brief: SSY Group Obtains NMPA Approval For Methocarbamol Tablets (0.5G)
02/07/2026 02:37
BRIEF-SSY Group Obtains NMPA Approval For Methocarbamol Tablets (0.5G) July 2 (Reuters) - SSY Group Ltd 2005.HK:
OBTAINS NMPA APPROVAL FOR METHOCARBAMOL TABLETS (0.5G)
OBTAINS NMPA REGISTRATION APPROVAL FOR PHLOROGLUCINOL DIHYDRATE AS BULK DRUG
Further company coverage: 2005.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on SSY
See all newsBrief: SSY Group Receives NMPA China Approval For Sodium Cromoglicate Eye Drops 2%
Brief: SSY Group Obtains NMPA Approval For Nimodipine Oral Solution
Brief: SSY Group Appoints Wu Heng Yao As Executive Director
Brief: SSY Group Says Ziprasidone Mesilate Receives Registration Approval In China
Hong Kong's SSY Group H1 profit rises on infusion solutions growth